Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Anti-HIV monoclonal antibody VRC07-523LS safe and well-tolerated in phase I study

March 21, 2018

Idenix Pharmaceuticals, Merck & Co. patent novel tenofovir prodrugs

March 21, 2018

3BNC117 and 10-1074 antibody combination shows promise for HIV infection

March 15, 2018

Researchers present data on mRNA-based vaccine for HIV-1 infection

March 14, 2018

YIR-821 shows promise for HIV infection

March 13, 2018

Novel compounds for treating HIV infection identified at Gilead

March 9, 2018

Hetero Labs discovers novel betulinic acid analogues

March 7, 2018

FDA approves Trogarzo for multidrug-resistant HIV-1

March 7, 2018

Hetero Labs presents novel HIV inhibitors

Feb. 23, 2018

Case Western, Sangamo awarded grant to advance research on gene-edited T cells to treat HIV

Feb. 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026